These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8461268)

  • 21. Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Goodson J; Greden JF
    Psychopathology; 1991; 24(4):247-52. PubMed ID: 1754657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressive and negative symptoms in major psychiatric disorders.
    Kitamura T; Suga R
    Compr Psychiatry; 1991; 32(1):88-94. PubMed ID: 2001626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS.
    Norman RM; Malla AK; Cortese L; Diaz F
    Schizophr Res; 1996 Mar; 19(1):73-85. PubMed ID: 9147498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliability and validity of the Chinese versions of the Scales for Assessment of Positive and Negative Symptoms.
    Phillips MR; Xiong W; Wang RW; Gao YH; Wang XQ; Zhang NP
    Acta Psychiatr Scand; 1991 Oct; 84(4):364-70. PubMed ID: 1746289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multivantaged assessment of depression in schizophrenia.
    Lindenmayer JP; Kay SR; Plutchik R
    Psychiatry Res; 1992 Jun; 42(3):199-207. PubMed ID: 1496052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls.
    Engel M; Lincoln TM
    Psychiatry Res; 2017 Jan; 247():1-5. PubMed ID: 27863311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability.
    von Knorring L; Lindström E
    Acta Psychiatr Scand; 1992 Dec; 86(6):463-8. PubMed ID: 1281960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Negative schizophrenic symptoms and their detection].
    Kukla F; Gold R
    Fortschr Neurol Psychiatr; 1991 Feb; 59(2):60-6. PubMed ID: 2026379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
    Thompson PA; Buckley PF; Meltzer HY
    J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of psychiatric experience and interrater reliability in assessment of negative symptoms.
    Müller MJ; Davids E
    J Nerv Ment Dis; 1999 May; 187(5):316-8. PubMed ID: 10348090
    [No Abstract]   [Full Text] [Related]  

  • 31. Interrater reliability of the Structured Clinical Interview for DSM-III-R, Axis II: schizophrenia spectrum and affective spectrum disorders.
    Fogelson DL; Nuechterlein KH; Asarnow RF; Subotnik KL; Talovic SA
    Psychiatry Res; 1991 Oct; 39(1):55-63. PubMed ID: 1771209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrater reliability of the Japanese version of the Positive and Negative Syndrome Scale and the appraisal of its training effect.
    Igarashi Y; Hayashi N; Yamashina M; Otsuka N; Kuroki N; Anzai N; Kazamatsuri H
    Psychiatry Clin Neurosci; 1998 Oct; 52(5):467-70. PubMed ID: 10215006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia.
    Garcia-Alvarez L; Garcia-Portilla MP; Saiz PA; Fonseca-Pedrero E; Bobes-Bascaran MT; Gomar J; Muñiz J; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(3):169-175. PubMed ID: 29628403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison.
    Kay SR
    Psychiatr Q; 1990; 61(3):163-78. PubMed ID: 2075220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing positive and negative symptoms in children and adolescents.
    Fields JH; Grochowski S; Lindenmayer JP; Kay SR; Grosz D; Hyman RB; Alexander G
    Am J Psychiatry; 1994 Feb; 151(2):249-53. PubMed ID: 8296898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inter--rater and test--retest reliability of the Japanese version of the subjective deficit syndrome scale.
    Kokai M; Inada T; Ohara K; Shimizu M; Iwado H; Morita Y
    Hum Psychopharmacol; 2003 Mar; 18(2):145-9. PubMed ID: 12590409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining and measuring negative symptoms of schizophrenia in clinical trials.
    Marder SR; Kirkpatrick B
    Eur Neuropsychopharmacol; 2014 May; 24(5):737-43. PubMed ID: 24275698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
    Bischof M; Obermann C; Hartmann MN; Hager OM; Kirschner M; Kluge A; Strauss GP; Kaiser S
    BMC Psychiatry; 2016 Nov; 16(1):415. PubMed ID: 27876020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS).
    Haddock G; McCarron J; Tarrier N; Faragher EB
    Psychol Med; 1999 Jul; 29(4):879-89. PubMed ID: 10473315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS).
    Khan A; Yavorsky WC; Liechti S; DiClemente G; Rothman B; Opler M; DeFries A; Jovic S
    J Clin Psychopharmacol; 2013 Feb; 33(1):109-17. PubMed ID: 23277234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.